F. Hölzel

1.1k total citations
44 papers, 959 citations indexed

About

F. Hölzel is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, F. Hölzel has authored 44 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Genetics and 11 papers in Oncology. Recurrent topics in F. Hölzel's work include Estrogen and related hormone effects (6 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Genetic Syndromes and Imprinting (3 papers). F. Hölzel is often cited by papers focused on Estrogen and related hormone effects (6 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Genetic Syndromes and Imprinting (3 papers). F. Hölzel collaborates with scholars based in Germany, United States and Russia. F. Hölzel's co-authors include K.-D. Schulz, Wolfgang Simon, Manfred Dietel, Regina Kunzmann, M. Albrecht, H. Maaß, Kay Friedrichs, M. Becker, Olaf Ortmann and Günter Emons and has published in prestigious journals such as Journal of Molecular Biology, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

In The Last Decade

F. Hölzel

41 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Hölzel Germany 15 379 309 293 249 142 44 959
Susan L. Fitzpatrick United States 9 554 1.5× 464 1.5× 302 1.0× 209 0.8× 35 0.2× 10 1.2k
A.M. de Leeuw Netherlands 17 581 1.5× 142 0.5× 210 0.7× 263 1.1× 108 0.8× 23 1.5k
Arend Brinkman Netherlands 18 740 2.0× 354 1.1× 180 0.6× 64 0.3× 114 0.8× 25 1.2k
Marie‐Thérèse Groyer‐Picard France 15 419 1.1× 394 1.3× 109 0.4× 172 0.7× 55 0.4× 20 1.1k
Nicole Manning United States 9 416 1.1× 500 1.6× 398 1.4× 132 0.5× 33 0.2× 11 971
Ralph Hamilton United States 15 397 1.0× 72 0.2× 198 0.7× 140 0.6× 80 0.6× 26 944
S.R. Glasser United States 19 377 1.0× 316 1.0× 76 0.3× 176 0.7× 89 0.6× 31 1.2k
John R. Morrison Australia 23 1.0k 2.7× 267 0.9× 94 0.3× 340 1.4× 65 0.5× 30 1.6k
Isabelle Allemand France 18 661 1.7× 256 0.8× 158 0.5× 293 1.2× 63 0.4× 40 1.3k
Jeffrey B. Virgin United States 14 473 1.2× 224 0.7× 67 0.2× 134 0.5× 37 0.3× 23 836

Countries citing papers authored by F. Hölzel

Since Specialization
Citations

This map shows the geographic impact of F. Hölzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Hölzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Hölzel more than expected).

Fields of papers citing papers by F. Hölzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Hölzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Hölzel. The network helps show where F. Hölzel may publish in the future.

Co-authorship network of co-authors of F. Hölzel

This figure shows the co-authorship network connecting the top 25 collaborators of F. Hölzel. A scholar is included among the top collaborators of F. Hölzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Hölzel. F. Hölzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedrichs, Kay, F. Hölzel, & F. Jänicke. (2002). Combination of taxanes and anthracyclines in first-line chemotherapy of metastatic breast cancer. European Journal of Cancer. 38(13). 1730–1738. 14 indexed citations
2.
Wilhelm, Stefan, et al.. (2000). IFN-γ-Induced Change in Microtubule Organization and α-Tubulin Expression During Growth Inhibition of Lung Squamous Carcinoma Cells. Journal of Interferon & Cytokine Research. 20(11). 983–990. 9 indexed citations
3.
Klouche, Mariam, Holger Kirchner, & F. Hölzel. (1995). Antiproliferative and Recovery Effects During Treatment of Breast and Ovarian Carcinoma Cell Cultures with Interferon-γ. Journal of Interferon & Cytokine Research. 15(4). 285–289. 2 indexed citations
4.
Friedrichs, Kay, Folker E. Franke, H.-J. Terpe, et al.. (1995). CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. PubMed. 55(22). 5424–33. 138 indexed citations
5.
Emons, Günter, Olaf Ortmann, M. Becker, et al.. (1993). High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.. PubMed. 53(22). 5439–46. 169 indexed citations
6.
Simon, Wolfgang, et al.. (1993). Effects of tamoxifen on human breast cancer cells in vitro. Archives of Gynecology and Obstetrics. 253(3). 131–141. 1 indexed citations
7.
Steffen, Martín, et al.. (1992). Karyotype instability and altered differentiation of rat sarcoma cells after retroviral infection. Genes Chromosomes and Cancer. 4(1). 46–57. 6 indexed citations
8.
Hofmann, Jeffrey W., et al.. (1991). Androgen sensitivity of the new human breast cancer cell line MFM-223.. PubMed. 51(20). 5722–7. 72 indexed citations
9.
Hackenberg, Reinhard, et al.. (1990). Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth. Journal of Cancer Research and Clinical Oncology. 116(5). 492–498. 17 indexed citations
10.
Westphal, Manfred, et al.. (1989). Spectrum of karyotypic aberrations in cultured human meningiomas. Cytogenetic and Genome Research. 52(1-2). 45–49. 19 indexed citations
11.
Westley, Bruce R., F. Hölzel, & Felicity E. B. May. (1989). Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line. Journal of Steroid Biochemistry. 32(3). 365–372. 24 indexed citations
12.
Hofmann, Jürgen, et al.. (1989). Characterization of epidermal growth factor-related proteins from human urinary chorionic gonadotrophin. Journal of Endocrinology. 123(2). 333–340. 11 indexed citations
13.
Westphal, Manfred, et al.. (1988). Glioma Biology in vitro: Goals and Concepts. PubMed. 43. 107–113. 6 indexed citations
14.
Drescher, Axel, et al.. (1987). Growth regulation of human endometrial carcinoma cells by steroid hormones and growth factors. Journal of Steroid Biochemistry. 28. 53–53. 1 indexed citations
15.
Dietel, Manfred, et al.. (1985). [Breast cancers in vitro: cytoskeleton, tumor markers, cell nuclear DNA and growth rate in relation to hormones and cytostatics].. PubMed. 69. 212–7. 2 indexed citations
16.
Simon, Wolfgang, et al.. (1985). In Vitro Modulation of Prolactin Binding to Human Mammary Carcinoma Cells by Steroid Hormones and Prolactin*. The Journal of Clinical Endocrinology & Metabolism. 60(6). 1243–1249. 22 indexed citations
17.
18.
Hölzel, F., et al.. (1983). Transition of non-malignant rat mammary tumor cells to the malignant state. Cell Biology International Reports. 7(7). 555–556. 1 indexed citations
19.
Hölzel, F. & F. Sokol. (1974). Integration of progeny simian virus 40 DNA into the host cell genome. Journal of Molecular Biology. 84(3). 423–444. 34 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan L. Fitzpatrick Breakdown of academic impact, for papers by A.M. de Leeuw Breakdown of academic impact, for papers by Arend Brinkman Breakdown of academic impact, for papers by Marie‐Thérèse Groyer‐Picard Breakdown of academic impact, for papers by Nicole Manning Breakdown of academic impact, for papers by Ralph Hamilton Breakdown of academic impact, for papers by S.R. Glasser Breakdown of academic impact, for papers by John R. Morrison Breakdown of academic impact, for papers by Isabelle Allemand Breakdown of academic impact, for papers by Jeffrey B. Virgin
Rankless by CCL
2026